Cytokinetics, Inc. (CYTK)
74.34
-0.50
(-0.67%)
USD |
NASDAQ |
May 07, 13:09
Cytokinetics Free Cash Flow : -548.92M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Bristol Myers Squibb Co. | 11.91B |
| Johnson & Johnson | 17.80B |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
| Edgewise Therapeutics, Inc. | -144.07M |
| Moderna, Inc. | -1.603B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -145.46M |
| Cash from Investing (Quarterly) | 145.49M |
| Cash from Financing (Quarterly) | 7.77M |
| Free Cash Flow Per Share (Quarterly) | -1.228 |
| Free Cash Flow to Equity (Quarterly) | -155.87M |
| Free Cash Flow to Firm (Quarterly) | -118.05M |
| Free Cash Flow Yield | -6.09% |